Literature DB >> 17440980

Labeling and identification of LNCaP cell surface proteins: a pilot study.

Hayley C Whitaker1, David P B Stanbury, Claire Brinham, Joanne Girling, Sarah Hanrahan, Nick Totty, David E Neal.   

Abstract

BACKGROUND: Membrane proteins provide the interface between the cell and its environment and are responsible for cell adhesion, mobility, and intracellular signaling. Previous studies have focused on the LNCaP whole cell proteome and transcriptome but little is known about proteins at the prostate cell membrane and how they change in response to androgens.
MATERIALS AND METHODS: Following treatment with R1881 or vehicle, membrane proteins of the prostate cancer LNCaP cell line were tagged with biotin using EZ-link sulfo-NHS-LC-biotin. Using the tag membrane proteins were purified and separated using two-dimensional gel electrophoresis and identified using mass spectrometry. E-cadherin and low density lipoprotein receptor (LDLR) were used as positive controls and also investigated following bicalutamide treatment. Membrane localization and androgen-regulation of proteins was confirmed using sub-cellular fractionation, Western blotting and microscopy.
RESULTS: We have demonstrated efficient and specific protein biotinylation and purification of LNCaP plasma membrane proteins using Western analysis. E-cadherin and LDLR were regulated at the cell surface in response to R1881 and bicalutamide. Mass spectrometry identified several androgen-regulated membrane associated proteins including Prx-3 and GRP78 which are known to localize to other cellular compartments as well as the plasma membrane. We confirmed the localization of the identified proteins in LNCaP cells by co-localization with E-cadherin and immunohistochemistry of prostate tissue.
CONCLUSION: Cell surface biotinylation is an effective technique for identifying membrane proteins in the LNCaP prostate cancer cell line. We have demonstrated the identification of androgen-regulated membrane proteins and their validation in tissue samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440980     DOI: 10.1002/pros.20580

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation.

Authors:  Punit Shah; Xiangchun Wang; Weiming Yang; Shadi Toghi Eshghi; Shisheng Sun; Naseruddin Hoti; Lijun Chen; Shuang Yang; Jered Pasay; Abby Rubin; Hui Zhang
Journal:  Mol Cell Proteomics       Date:  2015-08-09       Impact factor: 5.911

2.  Identification of proteins associating with glycosylphosphatidylinositol- anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78/BiP in T-cadherin-dependent cell survival.

Authors:  Maria Philippova; Danila Ivanov; Manjunath B Joshi; Emmanouil Kyriakakis; Katharina Rupp; Taras Afonyushkin; Valery Bochkov; Paul Erne; Therese J Resink
Journal:  Mol Cell Biol       Date:  2008-04-14       Impact factor: 4.272

3.  HSP70s: From Tumor Transformation to Cancer Therapy.

Authors:  Chih-Wen Shu; Chun-Ming Huang
Journal:  Clin Med Oncol       Date:  2008-04-24

4.  Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells.

Authors:  H L Bennett; J T Fleming; J O'Prey; K M Ryan; H Y Leung
Journal:  Cell Death Dis       Date:  2010-09-09       Impact factor: 8.469

5.  Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.

Authors:  H C Whitaker; D Patel; W J Howat; A Y Warren; J D Kay; T Sangan; J C Marioni; J Mitchell; S Aldridge; H J Luxton; C Massie; A G Lynch; D E Neal
Journal:  Br J Cancer       Date:  2013-07-23       Impact factor: 7.640

6.  The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing.

Authors:  Hayley J Luxton; Benjamin S Simpson; Ian G Mills; Nicola R Brindle; Zeba Ahmed; Vasilis Stavrinides; Susan Heavey; Stefan Stamm; Hayley C Whitaker
Journal:  Cancers (Basel)       Date:  2019-08-23       Impact factor: 6.639

7.  Regulation of the localisation and function of the oncogene LYRIC/AEG-1 by ubiquitination at K486 and K491.

Authors:  Hayley J Luxton; Karin Barnouin; Gavin Kelly; Sarah Hanrahan; Nick Totty; David E Neal; Hayley C Whitaker
Journal:  Mol Oncol       Date:  2014-01-24       Impact factor: 6.603

8.  Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.

Authors:  Sabina Luszczak; Benjamin S Simpson; Urszula Stopka-Farooqui; Vignesh Krishna Sathyadevan; Lina M Carmona Echeverria; Christopher Kumar; Helena Costa; Aiman Haider; Alex Freeman; Charles Jameson; Marzena Ratynska; Imen Ben-Salha; Ashwin Sridhar; Greg Shaw; John D Kelly; Hayley Pye; Kathy A Gately; Hayley C Whitaker; Susan Heavey
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.